Article
Epigenetic targeting in pancreatic cancer
4 Jan 2014
Abstract excerpt
The prognosis of pancreatic cancer patients is very poor, with a 5-year survival of less than 6%. Therefore, there is an urgent need for new therapeutic options in pancreatic cancer. In the past years it became evident that deregulation of epigenetic mechanisms plays an important role in pancreatic carcinogenesis. This review focuses on the exploitation of drugs that alter histone modifications, DNA methylation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
